Advances in the critical care management for patients with hematological malignancies
Élie Azoulay(Hôpital Saint-Louis), Ignacio Martín‐Loeches(St. James's Hospital), Sara Fernández(Universidad Complutense de Madrid), Antoine Lafarge(Inserm), Michael von Bergwelt‐Baildon(German Cancer Research Center), Márcio Soares(University of Copenhagen), Kathleen Puntillo(Department of Physiological Sciences), Naïke Bigé(Sorbonne Université), Bruno L. Ferreyro(University Health Network), Matthias Kochanek(Centrum für Integrierte Onkologie), Sandrine Valade(Inserm), Alexander Shimabukuro‐Vornhagen(Centrum für Integrierte Onkologie), Joseph Nates(The University of Texas MD Anderson Cancer Center), Lene Russell(University of Copenhagen), Éric Mariotte(Hôpital Saint-Louis), Emmanuel Canet(Centre Hospitalier Universitaire de Nantes), Frédéric Pène(Centre National de la Recherche Scientifique), Philippe R. Bauer(Mayo Clinic in Florida), Thomas Staudinger(Vienna General Hospital), Virginie Lemiale(Université Paris Cité), Laveena Munshi(University of Toronto), Alexis Maillard(Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Judith E. Nelson(Memorial Sloan Kettering Cancer Center), Dara Chean(Inserm), Lara Zafrani(Inserm), Cristina Gutiérrez(The University of Texas MD Anderson Cancer Center), Pedro Castro(Hospital Clínic de Barcelona), Michaël Darmon(Inserm), Alexandre Demoule(Inserm), Kathryn Puxty(NHS Greater Glasgow and Clyde), Peter Schellongowski(Charles University), Boris Boell(Centrum für Integrierte Onkologie)
Cited by 12
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k